Cysteine Sulfenylation of p-GSK-3β Drives Liver Insulin Resistance
In a groundbreaking study published recently in Nature Metabolism, researchers have unveiled a sophisticated molecular mechanism that sheds new light ...
Tag: therapeutic targets for fatty liver disease
Arginase 1 Drives Liver Fat via ERK2/PPARγ Pathway
In a groundbreaking study poised to reshape our understanding of liver metabolism, researchers have unveiled a novel mechanism by which ...
AKAP1 Loss Worsens MASLD via GPAT1 Activation
In a groundbreaking advancement poised to reshape our understanding of metabolic associated steatotic liver disease (MASLD), researchers have uncovered a ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!